Cardiologists: Big data advances research, but shouldn't do so at the cost of privacy

February 24, 2020

We know we shouldn't, but most of us have clicked "agree" in a hurry to download an app or sign up for a streaming service without reading the user agreement in detail.

And it might seem pretty safe to add an app that promises to help take control of your health through simple things like tracking your steps, measuring your blood pressure or noting your eating and exercise habits. But doctors who appreciate the research potential of incorporating big data into medical care are also warning about the need to manage the risk of exposing such health data while it's still possible to do so.

That's because the average patient probably has no idea about the complex rules around what happens to their sensitive health data when it is collected by apps. For instance, a 2019 study found 19 out of 24 health-related apps studied shared their users' data. Patient privacy laws preclude providers from sharing information, but the commercially available apps used to collect it don't necessarily have to follow HIPAA, the law that governs privacy about health information.

"Some health data shared with a physician in the context of a health-related interaction is protected, but in a different context that same data is not protected," says Jessica Golbus, M.D., a cardiovascular medicine fellow at the Michigan Medicine Frankel Cardiovascular Center. "The way the U.S. addresses health data focuses on who is using the data, but not the data itself."

This lack of protection could lead to people's sensitive data becoming available to unscrupulous third parties with sales interests, or those making decisions about life or disability insurance or employment, she says.

She authored a new perspective to highlight these consequences, published in the February 25 issue of Circulation, with two members of the University of Michigan's Institute for Healthcare Policy & Innovation: Brahmajee Nallamothu, M.D., MPH, also with the Frankel CVC, and W. Nicholson Price II, J.D., Ph.D., also with the U-M Law School.

Benefits outweigh risks - so far

Imagine getting a text message on a sunny day to remind you to go for a walk if you're trying to keep up your momentum after cardiac rehab, or a notification popping up with a sleep tip if your smartwatch finds you haven't gotten enough ZZZ's this week. Without advanced consumer devices that allow for data collection and synthesis, these kinds of interactions would still be a faraway dream. But these interventions are already here, or just around the corner.

And they have the potential to help patients better manage their own health, the authors believe.

"We're learning how to leverage digital technology, like smartphones and wearables, to engage patients in their health, improve remote monitoring of health conditions and potentially deliver targeted interventions outside of the clinic appointment," Golbus says.

The authors say they don't want to scare patients or providers away from embracing these potential improvements to research and patient care, because the benefits presently outweigh the risks. However, the risks of commercial exploitation and privacy harms should be addressed, they write.

"We simply think it's important to make sure providers who are encouraging their patients to use this technology are also able to have conversations with their patients about data privacy," Golbus says.

The need for education and advocacy

Golbus and colleagues suggest urgently addressing two areas: provider education and legislation. This, they believe, would help researchers continue to harness more data than they've ever had access to before to improve health and disease prevention and treatment, while also protecting their patients' privacy.

"It could be helpful for patients to provide doctors with their heart rate and blood pressure measurements collected using wearable devices," co-author Nallamothu added. "But this means we have a responsibility to educate patients and ourselves about potential downstream uses of that data."

This is a problem that will be difficult for consumers to solve on their own, the authors say.

As in many other commercial areas, data are being collected at large scale with little understanding by the public. Beyond the need for health care providers to learn about and raise awareness of the risks to using commercially available applications, the authors say the government should also ensure better protection of consumer data.

The responsibility shouldn't be placed only on the shoulders of consumers worrying about to whom they've consented to data sharing, they write.

"The U.S. is living in the past with regard to data protection," co-author Price says. "We've got privacy law from a world where health data means what your doctor writes in your medical chart. We're not in that world anymore. The law needs to change."
-end-
Paper cited: "Privacy Gaps for Digital Cardiology Data," Circulation. DOI: 10.1161/CIRCULATIONAHA.119.044966

For pre-embargo copies of the manuscript, contact the AHA/ASA News Media relations office at 214-706-1173 or ahacommunications@heart.org.

Michigan Medicine - University of Michigan

Related Blood Pressure Articles from Brightsurf:

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

High blood pressure treatment linked to less risk for drop in blood pressure upon standing
Treatment to lower blood pressure did not increase and may decrease the risk of extreme drops in blood pressure upon standing from a sitting position.

Changes in blood pressure control over 2 decades among US adults with high blood pressure
National survey data were used to examine how blood pressure control changed overall among U.S. adults with high blood pressure between 1999-2000 and 2017-2018 and by age, race, insurance type and access to health care.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

Effect of reducing blood pressure medications on blood pressure control in older adults
Whether the amount of blood pressure medications taken by older adults could be reduced safely and without a significant change in short-term blood pressure control was the objective of this randomized clinical trial that included 534 adults 80 and older.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Here's something that will raise your blood pressure
The apelin receptor (APJ) has been presumed to play an important role in the contraction of blood vessels involved in blood pressure regulation.

New strategy for treating high blood pressure
The key to treating blood pressure might lie in people who are 'resistant' to developing high blood pressure even when they eat high salt diets, shows new research published today in Experimental Physiology.

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.

Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.

Read More: Blood Pressure News and Blood Pressure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.